Porton Pharma Solutions Ltd. (SHE:300363)
24.72
+0.12 (0.49%)
Oct 21, 2025, 2:47 PM CST
Porton Pharma Solutions Revenue
Porton Pharma Solutions had revenue of 819.78M CNY in the quarter ending June 30, 2025, with 21.56% growth. This brings the company's revenue in the last twelve months to 3.28B, up 22.38% year-over-year. In the year 2024, Porton Pharma Solutions had annual revenue of 3.01B, down -17.87%.
Revenue (ttm)
3.28B
Revenue Growth
+22.38%
P/S Ratio
4.07
Revenue / Employee
781.15K
Employees
4,214
Market Cap
13.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.01B | -655.45M | -17.87% |
Dec 31, 2023 | 3.67B | -3.37B | -47.87% |
Jan 1, 2023 | 7.03B | 3.93B | 126.55% |
Jan 1, 2022 | 3.11B | 1.03B | 49.87% |
Dec 31, 2020 | 2.07B | 520.58M | 33.56% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Huadong Medicine | 42.62B |
WuXi AppTec | 41.90B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Jiangsu Hengrui Medicine | 30.15B |
Zhejiang NHU Company | 22.87B |
Aier Eye Hospital Group | 21.94B |